Evidence map›Paper›PMID 41415468›Full record

ArticlebioRxiv : the preprint server for biology2025

OddSNP: a predictive framework for optimizing multiplexed single-cell RNA-seq experiments.

Rodolfo S Allendes Osorio, Toshiya Nishimura, Yuichi Shigihara, Masaki Kimura, Takanori Takebe, Takahiro Nemoto

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rodolfo S Allendes OsorioPremium Research Institute for Human Metaverse Medicine (WPI-PRIMe), The University of Osaka, 2-2 Yamadaoka, Suita-shi 565-9315, Osaka, Japan.ORCID 0000-0002-9627-9338
Toshiya NishimuraPremium Research Institute for Human Metaverse Medicine (WPI-PRIMe), The University of Osaka, 2-2 Yamadaoka, Suita-shi 565-9315, Osaka, Japan.
Yuichi ShigiharaPremium Research Institute for Human Metaverse Medicine (WPI-PRIMe), The University of Osaka, 2-2 Yamadaoka, Suita-shi 565-9315, Osaka, Japan.
Masaki KimuraCenter for Stem Cell and Organoid Medicine (CuSTOM), Division of Gastroenterology, Hepatology and Nutrition, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, 45229, OH, USA.
Takanori TakebePremium Research Institute for Human Metaverse Medicine (WPI-PRIMe), The University of Osaka, 2-2 Yamadaoka, Suita-shi 565-9315, Osaka, Japan.ORCID 0000-0002-6989-3041
Takahiro NemotoPremium Research Institute for Human Metaverse Medicine (WPI-PRIMe), The University of Osaka, 2-2 Yamadaoka, Suita-shi 565-9315, Osaka, Japan.ORCID 0000-0003-2981-4035

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Engineering multi-organs in a dishDP2DK128799 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI TAKEBE, TAKANORI · 2020 to 2020
$2.3M
Modeling diabetes using an integrated plate systemUG3DK119982 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI LEE, MOO-YEAL, WELLS, JAMES M · 2018 to 2019
$1.7M
Organoid-guided Precision Hepatology for SteatohepatitisR01DK135478 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Takanori Takebe · 2024 to 2026
$1.6M
NIDDK NIH HHS DP2 DK128799NIDDK NIH HHS P30 DK078392NIDDK NIH HHS R01 DK135478NIDDK NIH HHS UG3 DK119982
6 · The paper itself

Abstract

Donor multiplexing is a powerful strategy to increase scale, lower the costs, and reduce batch effects in single-cell RNA sequencing (scRNAseq), but clear guidelines for experimental design are lacking, forcing researchers to risk costly demultiplexing failures. To address this, we introduce SNP-Information Content (SNP-IC), a quantitative metric computable from simple unpooled pilot data that accurately predicts the success of genotype-based demultiplexing. Across multiple large-scale datasets using stem cell and organoid models, we establish a robust SNP-IC threshold of approximately 50, above which cells can be reliably assigned to their donor of origin. For more challenging genotype-free approaches, we define a pairwise metric, cpSNP-IC, and demonstrate a much higher requirement of approximately 3,000. Our open-source framework,

Indexed as

demultiplexinghuman liver organoidsscRNAseqSNP

Identifiers

PMID41415468
PMCPMC12710642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.